Centene (CNC) Competitors $55.49 -0.27 (-0.49%) Closing price 06/10/2025 03:59 PM EasternExtended Trading$55.53 +0.04 (+0.08%) As of 04:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUEShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry. Centene vs. Elevance Health The Cigna Group Humana Molina Healthcare UnitedHealth Group Oscar Health Alignment Healthcare Trupanion Clover Health Investments NeueHealth Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership. Which has preferable earnings and valuation, ELV or CNC? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$183.12B0.47$5.98B$25.6314.98Centene$169.28B0.16$3.31B$6.718.27 Is ELV or CNC more profitable? Elevance Health has a net margin of 3.38% compared to Centene's net margin of 2.03%. Elevance Health's return on equity of 18.28% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health3.38% 18.28% 6.72% Centene 2.03%13.85%4.54% Do analysts recommend ELV or CNC? Elevance Health presently has a consensus price target of $498.87, suggesting a potential upside of 29.92%. Centene has a consensus price target of $77.71, suggesting a potential upside of 40.06%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75Centene 0 Sell rating(s) 7 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.56 Do institutionals & insiders have more ownership in ELV or CNC? 89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, ELV or CNC? Elevance Health has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Does the MarketBeat Community favor ELV or CNC? Centene received 173 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.13% of users gave Centene an outperform vote while only 67.30% of users gave Elevance Health an outperform vote. CompanyUnderperformOutperformElevance HealthOutperform Votes88367.30% Underperform Votes42932.70% CenteneOutperform Votes105673.13% Underperform Votes38826.87% Does the media prefer ELV or CNC? In the previous week, Elevance Health had 34 more articles in the media than Centene. MarketBeat recorded 52 mentions for Elevance Health and 18 mentions for Centene. Centene's average media sentiment score of 0.88 beat Elevance Health's score of 0.55 indicating that Centene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 25 Very Positive mention(s) 3 Positive mention(s) 21 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Centene 10 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryElevance Health beats Centene on 12 of the 18 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$27.75B$44.04B$5.57B$19.81BDividend YieldN/A2.02%5.27%3.85%P/E Ratio8.8917.8227.2035.71Price / Sales0.160.53412.9245.94Price / Cash5.9123.1938.2517.52Price / Book1.044.707.114.84Net Income$3.31B$2.21B$3.23B$1.02B7 Day Performance0.16%0.15%4.61%2.35%1 Month Performance-11.67%-6.09%13.35%5.86%1 Year Performance-20.54%20.58%31.75%14.72% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9404 of 5 stars$55.49-0.5%$77.71+40.1%-20.5%$27.75B$169.28B8.8974,300Analyst ForecastAnalyst RevisionELVElevance Health4.8539 of 5 stars$377.08-1.8%$499.53+32.5%-28.4%$85.20B$183.12B14.72102,300Trending NewsAnalyst ForecastCIThe Cigna Group4.9911 of 5 stars$314.83-0.6%$379.50+20.5%-7.4%$84.10B$254.47B25.7271,300Positive NewsAnalyst RevisionHUMHumana4.551 of 5 stars$230.96-0.9%$284.48+23.2%-33.6%$27.87B$120.26B23.2167,100Analyst RevisionMOHMolina Healthcare4.7414 of 5 stars$297.40-2.5%$364.54+22.6%-4.1%$16.12B$41.87B14.5615,000Trending NewsAnalyst ForecastAnalyst RevisionUNHUnitedHealth Group4.9963 of 5 stars$304.27+0.8%$439.17+44.3%-38.6%$276.01B$410.06B19.63400,000Trending NewsDividend IncreaseAnalyst RevisionHigh Trading VolumeOSCROscar Health2.024 of 5 stars$14.27+3.4%$18.50+29.7%-28.5%$3.63B$10.08B-712.892,710Positive NewsAnalyst DowngradeHigh Trading VolumeALHCAlignment Healthcare2.0912 of 5 stars$15.49+0.7%$17.17+10.9%+75.0%$3.06B$3.00B-20.11850Positive NewsTRUPTrupanion2.15 of 5 stars$46.73-1.0%$51.80+10.9%+86.0%$2.00B$1.32B-203.171,130CLOVClover Health Investments2.5578 of 5 stars$3.18+1.1%$4.83+52.2%+203.4%$1.62B$1.49B-15.87680Positive NewsNEUENeueHealth1.038 of 5 stars$6.84-0.5%$7.00+2.4%+21.6%$61.02M$907.35M-0.131,252 Related Companies and Tools Related Companies ELV Alternatives CI Alternatives HUM Alternatives MOH Alternatives UNH Alternatives OSCR Alternatives ALHC Alternatives TRUP Alternatives CLOV Alternatives NEUE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.